Intra-Cellular Therapies Inc. buy Robert W. Baird
Start price
03.01.24
/
50%
€64.00
Target price
03.01.25
€75.98
Performance (%)
-1.56%
Price
18:38
€63.00
Summary
This prediction is currently active. With a performance of -1.56%, the BUY prediction for Intra-Cellular Therapies Inc. by Robert_W__Baird is down slightly. This prediction currently runs until 03.01.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 3.306% | 3.306% |
iShares Core DAX® | -0.552% | 3.281% |
iShares Nasdaq 100 | -1.415% | 4.535% |
iShares Nikkei 225® | -0.877% | -1.739% |
iShares S&P 500 | -0.415% | 3.239% |
Comments by Robert_W__Baird for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $83.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Robert_W__Baird for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
18.04.24
18.04.24
€96.53
18.04.25
18.04.25
-8.03%
18:38
18:38